These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34289108)

  • 21. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.
    Oike Y; Akao M; Kubota Y; Suda T
    Trends Mol Med; 2005 Oct; 11(10):473-9. PubMed ID: 16154386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiopoietin-like proteins and postprandial partitioning of fatty acids.
    DiDonna NM; Chen YQ; Konrad RJ
    Curr Opin Lipidol; 2022 Feb; 33(1):39-46. PubMed ID: 34789669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Interplay between Angiopoietin-Like Proteins and Adipose Tissue: Another Piece of the Relationship between Adiposopathy and Cardiometabolic Diseases?
    Bini S; D'Erasmo L; Di Costanzo A; Minicocci I; Pecce V; Arca M
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension.
    Abu-Farha M; Cherian P; Qaddoumi MG; AlKhairi I; Sriraman D; Alanbaei M; Abubaker J
    Lipids Health Dis; 2018 Mar; 17(1):35. PubMed ID: 29490644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders.
    Morelli MB; Chavez C; Santulli G
    Expert Opin Ther Targets; 2020 Jan; 24(1):79-88. PubMed ID: 31856617
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment.
    Valiakou V; Eliadis P; Karamichali E; Tsitsilonis O; Koskinas J; Georgopoulou U; Foka P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of angiopoietin-like 4 in human cancer.
    Tan MJ; Teo Z; Sng MK; Zhu P; Tan NS
    Mol Cancer Res; 2012 Jun; 10(6):677-88. PubMed ID: 22661548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.
    Zheng J; Umikawa M; Cui C; Li J; Chen X; Zhang C; Huynh H; Kang X; Silvany R; Wan X; Ye J; Cantó AP; Chen SH; Wang HY; Ward ES; Zhang CC
    Nature; 2012 May; 485(7400):656-60. PubMed ID: 22660330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiopoietin-like proteins in multiple sclerosis.
    Al-Temaimi R; Cherian P; Abu-Farha M; Alroughani R
    J Neuroimmunol; 2019 May; 330():31-34. PubMed ID: 30784773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical angiopoietin-like protein that regulates ANGPTL3.
    Quagliarini F; Wang Y; Kozlitina J; Grishin NV; Hyde R; Boerwinkle E; Valenzuela DM; Murphy AJ; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19751-6. PubMed ID: 23150577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of lipid metabolism via angiopoietin-like proteins.
    Kersten S
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1059-62. PubMed ID: 16246045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.
    Harada M; Yamakawa T; Kashiwagi R; Ohira A; Sugiyama M; Sugiura Y; Kondo Y; Terauchi Y
    PLoS One; 2021; 16(7):e0255147. PubMed ID: 34293055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating angiopoietin-like proteins in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
    Ke Y; Liu S; Zhang Z; Hu J
    Lipids Health Dis; 2021 May; 20(1):55. PubMed ID: 34034750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiopoietins in angiogenesis and beyond.
    Tsigkos S; Koutsilieris M; Papapetropoulos A
    Expert Opin Investig Drugs; 2003 Jun; 12(6):933-41. PubMed ID: 12783598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue-specific epigenetics of atherosclerosis-related ANGPT and ANGPTL genes.
    Ehrlich KC; Lacey M; Ehrlich M
    Epigenomics; 2019 Feb; 11(2):169-186. PubMed ID: 30688091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk.
    Kersten S
    Curr Opin Lipidol; 2019 Jun; 30(3):205-211. PubMed ID: 30893111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiopoietin-like proteins stimulate HSPC development through interaction with notch receptor signaling.
    Lin MI; Price EN; Boatman S; Hagedorn EJ; Trompouki E; Satishchandran S; Carspecken CW; Uong A; DiBiase A; Yang S; Canver MC; Dahlberg A; Lu Z; Zhang CC; Orkin SH; Bernstein ID; Aster JC; White RM; Zon LI
    Elife; 2015 Feb; 4():. PubMed ID: 25714926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiopoietin inhibitors: A review on targeting tumor angiogenesis.
    Parmar D; Apte M
    Eur J Pharmacol; 2021 May; 899():174021. PubMed ID: 33741382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Not all angiopoietin-like proteins (Angptls) are created equal: insights from molecular, genetic, and pharmacological studies on the mechanism of LPL inhibition by Angptl3 and Angptl4.
    Li C
    Curr Opin Lipidol; 2009 Aug; 20(4):357-9. PubMed ID: 19584596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.